Does VOXELOTOR Cause Product dose omission issue? 5,122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,122 reports of Product dose omission issue have been filed in association with VOXELOTOR (OXBRYTA). This represents 23.4% of all adverse event reports for VOXELOTOR.
5,122
Reports of Product dose omission issue with VOXELOTOR
23.4%
of all VOXELOTOR reports
10
Deaths
2,362
Hospitalizations
How Dangerous Is Product dose omission issue From VOXELOTOR?
Of the 5,122 reports, 10 (0.2%) resulted in death, 2,362 (46.1%) required hospitalization, and 3 (0.1%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VOXELOTOR. However, 5,122 reports have been filed with the FAERS database.
What Other Side Effects Does VOXELOTOR Cause?
Sickle cell anaemia with crisis (11,023)
Diarrhoea (3,173)
Off label use (2,364)
Nausea (2,003)
Headache (1,683)
Abdominal pain upper (1,165)
Pain (1,059)
Therapy cessation (1,038)
Fatigue (1,004)
Abdominal discomfort (961)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which VOXELOTOR Alternatives Have Lower Product dose omission issue Risk?
VOXELOTOR vs VUTRISIRAN
VOXELOTOR vs VX-770
VOXELOTOR vs VX-950
VOXELOTOR vs VYVANSE
VOXELOTOR vs WARFARIN